Get free PhD updates, every week | SIGN UP NOW Get free PhD updates, every week | SIGN UP NOW

We have 45 Toxicology PhD Projects, Programmes & Scholarships PhD Projects, Programmes & Scholarships in the UK

Discipline

Discipline

Medicine

Location

Location

United Kingdom

Institution

Institution

All Institutions

PhD Type

PhD Type

All PhD Types

Funding

Funding

All Funding


Toxicology PhD Projects, Programmes & Scholarships PhD Projects, Programmes & Scholarships in the UK

We have 45 Toxicology PhD Projects, Programmes & Scholarships PhD Projects, Programmes & Scholarships in the UK

A PhD in Toxicology involves in-depth research to the effect of different chemicals on the health of organisms, especially humans. You could be investigating the impact of these toxins or focus on finding treatments for them.

What’s it like to study a PhD in Toxicology?

If you’re planning on studying a PhD In Toxicology, you could be monitoring how different toxins affect the health and wellbeing of humans or carry out assessments for risks to public health. A PhD in Toxicology is a highly interdisciplinary subject and you’ll be required to interact with concepts from other STEM fields like Biology, Chemistry, Medicine or Pharmacy.

Some popular Toxicology research topics are

  • Cellular signalling
  • Cell damage
  • Cell death
  • Aquatic toxicology
  • Medical toxicology
  • Forensic toxicology

At the end of your PhD, you will have produced a unique piece of research which has significant impact in your field. You will be required to submit an 80,000-word thesis to be defended in an oral viva examination.

Like other STEM subjects, PhDs in Toxicology are advertised with a research aim attached. Some universities are open to applicants proposing their own research, however, we highly recommend that you talk to a potential supervisor about the scope of your research before you make a formal application.

In the UK, you might have to apply into an MPhil programme to begin with, however, you can upgrade to a PhD once your supervisor is convinced that your work meets certain expectations

Some elements of a Toxicology PhD call for laboratory rotations and teaching modules that are meant to equip you with certain transferable skills. You might be asked to take these classes in the first year of your study.

Entry requirements

To be able to do a PhD in Toxicology, an application must hold an Upper Second Class Bachelors degree in a relevant subject like Biology or Medicine. In some cases, a Lower Second-Class degree will also be accepted if you also hold a Masters with at least a Merit qualification.

Depending on where you study, you might also have to submit language test results to show that you’ll understand the course content.

PhD in Toxicology funding options

In the UK, a PhD in Toxicology is funded by the Medical Research Council (MRC). They offer fully funded studentships along with a monthly stipend. If you’re applying for a PhD with funding already attached, you’ll get guaranteed funding if you’re successful in your application. If you’re proposing your own project, you’ll have to be accepted into a university and then apply for funding separately.

PhD in Toxicology careers

Toxicology doctoral graduates usually go on to work in forensics, healthcare, pharmaceuticals and governments. If you wish to continue your research, you can think of working as a postdoctoral research fellow or in academia.

read more
PhD saved successfully

Therapeutic resolution of pulmonary arterial hypertension (PAH) by natural products

  Research Group: Pharmacology and Experimental Therapeutics
Pulmonary arterial hypertension (PAH) is a devastating cardiovascular disorder which, if left untreated, leads to heart failure and death. Read more

Therapeutic resolution of coronavirus (COVID-19) diseases by natural products

  Research Group: Pharmacology and Experimental Therapeutics
Coronavirus now labelled as Covid-19 has become a global pandemic affecting around 200 countries. Currently neither any cure nor any vaccine for Covid-19 has been established. Read more

Targeting the MAPK scaffold protein KSR1 for the treatment of prostate cancer

  Research Group: Institute of Cancer Therapeutics
Prostate cancer is one of the leading causes of male cancer deaths. It arises when individual cells escape their normal growth control mechanisms and proliferate in an uncontrolled fashion. Read more

Re-purposing established drugs for the resolution of pulmonary arterial hypertension (PAH)

  Research Group: Pharmacology and Experimental Therapeutics
Pulmonary arterial hypertension (PAH) is a devastating cardiovascular disorder which, if left untreated, leads to heart failure and death. Read more

Polysialyltransferases as a target in metastatic cancer

  Research Group: Institute of Cancer Therapeutics
Polysialic acid plays an essential role in neuronal development, but by adulthood is absent from the human body. Its biosynthesis is regulated by two polysialyltransferases. Read more

Formulation of heterogenous solid dispersions produced by spray drying and hot-melt extrusion for improved delivery of amorphous drugs

  Research Group: Pharmacology and Experimental Therapeutics
Production of the amorphous solid dispersions (ASDs) is a one of the methods of improving of physicochemical properties of an active pharmaceutical ingredient (API) such as its solubility and physicochemical stability. Read more

Endosomal Sorting Complex Required for Transport (ESCRT): Investigation of the role in acquired drug resistance in colon cancer

  Research Group: Institute of Cancer Therapeutics
Despite treatment advances, one of the most common cancers, colorectal cancer (CRC), still has a 45% mortality rate, and one of the major problems is the build-up of resistance to cancer drugs during treatment (‘acquired resistance’) such that over time the drugs stop working. Read more

Discovery and Development of Biocatalytic Solutions to Mitigate Microplastic Pollution

  Research Group: Chemistry and Biosciences
Plastic contamination is a great ecological disaster facing modern society; a burden overwhelmingly heaped on the least economically developed countries. Read more

Development of Naked Mole Rat Colonic Crypt Models to Use in the Search for Bowel Disease Preventatives

  Research Group: Institute of Cancer Therapeutics
Diseases affecting the bowel such as colorectal cancer (CRC) and the inflammatory bowel diseases (IBD) ulcerative colitis and Crohn’s disease are major global healthcare challenges in the 21st century. Read more

Development of a personalized therapy for pulmonary arterial hypertension (PAH)

  Research Group: Pharmacology and Experimental Therapeutics
Pulmonary arterial hypertension (PAH) is a devastating cardiovascular disorder which, if left untreated, leads to heart failure and death. Read more

Design, synthesis and evaluation of protease-activated anti-cancer prodrugs

  Research Group: Institute of Cancer Therapeutics
Matrix metalloproteinases (MMPs) are a family of endoproteases that are overexpressed in tumours and play crucial roles in many tumourigenic processes, not least tumour invasion and angiogenesis. Read more

Design, synthesis and evaluation of novel polysialyltransferase inhibitors as anti- metastatic agents

  Research Group: Institute of Cancer Therapeutics
Polysialic acid plays an essential role in neuronal development, but by adulthood is absent from the human body. Its biosynthesis is regulated by two polysialyltransferases (polySTs). Read more

Filtering Results